Peptris Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Project Financing
- Latest Deal Amount
-
$8.98M
- Investors
-
10
Peptris General Information
Description
Developer of a drug-discovery platform designed to improve the efficiency of identifying therapeutic compounds. The company's platform uses artificial intelligence and generative models to create optimized molecular structures and reduce reliance on laboratory experiments, enabling pharmaceutical organizations to accelerate research while lowering costs.
Contact Information
Website
www.peptris.comCorporate Office
- Center for Cellular and Molecular Platforms (C-CAMP)
- NCBS-TIFR Campus, GKVK, Bellary Road
- Bangalore, Karnataka 560065
- India
Corporate Office
- Center for Cellular and Molecular Platforms (C-CAMP)
- NCBS-TIFR Campus, GKVK, Bellary Road
- Bangalore, Karnataka 560065
- India
Peptris Timeline
Peptris Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Project Financing | 12-Oct-2026 | $8.98M | Completed | Pre-Clinical Trials | ||
| 7. Later Stage VC (Series A) | 18-Feb-2026 | Completed | Pre-Clinical Trials | |||
| 6. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 5. Early Stage VC | 19-Dec-2023 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup | |||
| 3. Seed Round | 02-Nov-2021 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Peptris Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Pre-Seed CCPS | ||||||||
| CCPS | ||||||||
| Series Seed A Shares | 16,862 | $null | $18 | $18 | 1x | $18 | 11.5% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Peptris Comparisons
Industry
Financing
Details
Peptris Competitors (1)
One of Peptris’s competitors is ImmunitoAI, a Venture Capital-Backed company based in Bengaluru, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ImmunitoAI | Venture Capital-Backed | Bengaluru, India |
Peptris Signals
Peptris Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BYT Capital | Venture Capital | Minority | ||
| Indian Angel Network | Angel Group | Minority | ||
| Inflection Point Ventures (India) | Angel Group | Minority | ||
| Rainmatter Capital | Corporate Venture Capital | Minority | ||
| Tenacity Ventures | Growth/Expansion | Minority |
Peptris FAQs
-
When was Peptris founded?
Peptris was founded in 2019.
-
Where is Peptris headquartered?
Peptris is headquartered in Bangalore, India.
-
What is the size of Peptris?
Peptris has 10 total employees.
-
What industry is Peptris in?
Peptris’s primary industry is Drug Discovery.
-
Is Peptris a private or public company?
Peptris is a Private company.
-
What is Peptris’s current revenue?
The current revenue for Peptris is .
-
How much funding has Peptris raised over time?
Peptris has raised $18M.
-
Who are Peptris’s investors?
BYT Capital, Indian Angel Network, Inflection Point Ventures (India), Rainmatter Capital, and Tenacity Ventures are 5 of 10 investors who have invested in Peptris.
-
Who are Peptris’s competitors?
ImmunitoAI is a competitor of Peptris.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process